Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma

NCT00019175 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: fowlpox virus vaccine vector
BIOLOGICAL: gp100 antigen

Sponsor

National Cancer Institute (NCI)